Patients were randomly assigned to either tight intraoperative glucose control with a hyperinsulinemic-normoglycemic clamp ( target blood glucose , 80 to 110 mg/dl ) or standard therapy ( conventional insulin administration with blood glucose target , < 150 mg/dl ) .